International Journal of
Reproductive Biomedicine
Thu, Dec 5, 2024
[Archive]
Volume 13, Issue 4 (5-2015)
IJRM 2015, 13(4): 195-202 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Borges Cavalcante M, Silva Costa F D, Barini R, Araujo Júnior E. Granulocyte colony-stimulating factor and reproductive medicine: A review. IJRM 2015; 13 (4) :195-202
URL: http://ijrm.ir/article-1-640-en.html
URL: http://ijrm.ir/article-1-640-en.html
1- Department of Gynecology and Obstetrics, University of Fortaleza, Fortaleza-CE, Brazil
2- Department of Perinatal Medicine, Pregnancy Research Centre, University of Melbourne, The Royal Women’s Hospital, Melbourne, Victoria, Australia
3- Department of Obstetrics and Gynecology, State University of Campinas, Campinas-SP, Brazil
4- Department of Obstetrics, Paulista School of Medicine, São Paulo Federal University, São Paulo-SP, Brazil ,araujojred@terra.com.br
2- Department of Perinatal Medicine, Pregnancy Research Centre, University of Melbourne, The Royal Women’s Hospital, Melbourne, Victoria, Australia
3- Department of Obstetrics and Gynecology, State University of Campinas, Campinas-SP, Brazil
4- Department of Obstetrics, Paulista School of Medicine, São Paulo Federal University, São Paulo-SP, Brazil ,
Abstract: (2922 Views)
Background: Recently, the use of granulocyte colony-stimulating factor (G-CSF) has been proposed to improve pregnancy outcomes in reproductive medicine.
Objective: A systematic review of the current use of G-CSF in patients who have difficulty conceiving and maintaining pregnancy was performed.
Materials and Methods: Two electronic databases (PubMed/ Medline and Scopus) were searched. Study selection, data extraction and quality assessment were performed in duplicate. The subject codes used were granulocyte colony-stimulating factor, G-CSF, recurrent miscarriage, IVF failure, and endometrium.
Results: The search of electronic databases resulted in 215 citations (PubMed/ Medline: 139 and Scopus: 76), of which 38 were present in both databases. Of the remaining 177 publications, seven studies were included in the present review.
Conclusion: Treatment with G-CSF is a novel proposal for immune therapy in patients with recurrent miscarriage and implantation failure following cycles of IVF. However, a larger number of well-designed studies are required for this treatment to be established.
Objective: A systematic review of the current use of G-CSF in patients who have difficulty conceiving and maintaining pregnancy was performed.
Materials and Methods: Two electronic databases (PubMed/ Medline and Scopus) were searched. Study selection, data extraction and quality assessment were performed in duplicate. The subject codes used were granulocyte colony-stimulating factor, G-CSF, recurrent miscarriage, IVF failure, and endometrium.
Results: The search of electronic databases resulted in 215 citations (PubMed/ Medline: 139 and Scopus: 76), of which 38 were present in both databases. Of the remaining 177 publications, seven studies were included in the present review.
Conclusion: Treatment with G-CSF is a novel proposal for immune therapy in patients with recurrent miscarriage and implantation failure following cycles of IVF. However, a larger number of well-designed studies are required for this treatment to be established.
Keywords: Granulocyte colony-stimulating factor, Immunotherapy, Recurrent miscarriage, Reproductive medicine, Review.
Type of Study: Original Article |
References
1. Rai R, Regan L. Recurrent miscarriage. Lancet 2006; 368: 601-611. [DOI:10.1016/S0140-6736(06)69204-0]
2. Practice Committee of the American Society for Reproductive Medicine. Definitions of Infertility and Recurrent Pregnancy Loss: a committee opinion. Fertil Steril 2013; 99: 63. [DOI:10.1016/j.fertnstert.2012.09.023]
3. Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes 2009; 16: 446-450. [DOI:10.1097/MED.0b013e3283327fc5]
4. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod BioMed Online 2014; 28: 14-38. [DOI:10.1016/j.rbmo.2013.08.011]
5. Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by 'recurrent implantation failure'? A systematic review and opinion. Reprod BioMed Online 2014; 28: 409-423. [DOI:10.1016/j.rbmo.2013.12.006]
6. Kasius A, Smit JG, Torrance HL, Eijkemans MJC, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 2014; 20: 530-541. [DOI:10.1093/humupd/dmu011]
7. Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet 2006; 23: 337-342. [DOI:10.1007/s10815-006-9053-1]
8. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril 1997; 68: 927-930. [DOI:10.1016/S0015-0282(97)00330-0]
9. Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 2002; 78: 1073-1076. [DOI:10.1016/S0015-0282(02)03375-7]
10. Ledee-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod 2002; 17: 1249-1253. [DOI:10.1093/humrep/17.5.1249]
11. Qublan H, Amarin Z, Al-Quda M, Diab F, Nawasreh M, Malkawi S, et al. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of ≤7 mm on day of egg retrieval. Hum Fertil (Camb) 2008; 11: 43-47. [DOI:10.1080/14647270701704768]
12. Metcalf D. The Granulocyte-Macrophage Colony-Stimulating Factors. Science 1985; 229: 16-22. [DOI:10.1126/science.2990035]
13. Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, et al. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986; 319: 415-418. [DOI:10.1038/319415a0]
14. Thomas J, Liu F, Link DC. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol 2002; 9: 183-189. [DOI:10.1097/00062752-200205000-00002]
15. Root RK, Dale DC. Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor: Comparisons and Potential for Use in the Treatment of Infections in Nonneutropenic Patients. J Infect Dis 1999; 179: S342-S352. [DOI:10.1086/513857]
16. Uzumaki H, Okabe T, Sasaki N, Hagiwara K, Takaku F, Tobita M, et al. Identification and characterization of receptors for granulocyte colony stimulating factor on human placenta and trophoblastic cells. Proc Natl Acad Sci USA 1989; 86: 9323-9326. [DOI:10.1073/pnas.86.23.9323]
17. Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: A new challenging role for regulatory T cells. Placenta 2014; 35: 241-248. [DOI:10.1016/j.placenta.2014.02.004]
18. Mowbray SF, Gibbons C, Lidell H, Reginald PW, Underwood JL, Beard RW. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985; 1: 941-943. [DOI:10.1016/S0140-6736(85)91723-4]
19. Cavalcante MB, Costa FD, Araujo Júnior E, Barini R. Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy. J Matern Fetal Neonatal Med 2014; 28: 1-5.
20. Nyborg KM, Kolte AM, Larsen EC, Christiansen OB. Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2014; 102: 1650-1655. [DOI:10.1016/j.fertnstert.2014.08.029]
21. Shreeve N, Sadek K. Intralipid therapy for recurrent implantation failure: new hope or false dawn? J Reprod Immunol 2012; 93: 38-40. [DOI:10.1016/j.jri.2011.11.003]
22. Clark DA. Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion? Am J Reprod Immunol 2009; 61: 107-112. [DOI:10.1111/j.1600-0897.2008.00680.x]
23. Stern JJ, Coulam CB. Current status of immunologic recurrent pregnancy loss. Curr Opin Obstet Gynecol 1993; 5: 252-259. [DOI:10.1097/00001703-199304000-00014]
24. Litwin S, Lagadari M, Barrientos G, Roux ME, Margni R, Miranda S. Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am J Reprod Immunol 2005; 54: 311-320. [DOI:10.1111/j.1600-0897.2005.00317.x]
25. Kato Y, Kuwabara T, Itoh T, Hiura M, Hatori A, Shigematsu A, et al. A possible relationship between abortions and placental embolism in pregnant rabbits given human granulocyte colony-stimulating factor. J Toxicol Sci 2001; 26: 39-50. [DOI:10.2131/jts.26.39]
26. Würfel W, Santjohanser C, Hirv K, Bühl M, Meri O, Laubert I, et al. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunoglobulin-like receptors. Hum Reprod 2010; 25: 2151-2152. [DOI:10.1093/humrep/deq106]
27. Rahmati M, Petitbarat M, Dubanchet S, Bensussan A, Chaouat G, Ledee N. Granulocyte-Colony Stimulating Factor Related Pathways Tested on an Endometrial Ex-Vivo Model. Plos One 2014; 9: e102286. [DOI:10.1371/journal.pone.0102286]
28. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009; 24: 2703-2708. [DOI:10.1093/humrep/dep240]
29. Santjohanser C, Knieper C, Franz C, Hirv K, Meri O, Schleyer M, et al. Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch Immunol Ther Exp (Warsz) 2013; 61: 159-164. [DOI:10.1007/s00005-012-0212-z]
30. Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril 2011; 95: 13-17. [DOI:10.1016/j.fertnstert.2011.01.143]
31. Salmassi A, Schmutzler AG, Schaefer S, Koch K, Hedderich J, Jonat W, et al. Is granulocyte colony-stimulating factor level predictive for human IVF outcome? Hum Reprod 2005; 20: 2434-2440. [DOI:10.1093/humrep/dei071]
32. Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E, et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod 2013; 28: 172-177. [DOI:10.1093/humrep/des370]
33. Kunicki M, Łukaszuk K, Woclawek-Potocka I, Liss J, Kulwikowska P, Szczyptańska J. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization. Biomed Res Int 2014; 913235.
34. Li Y, Pan P, Chen X, Li L, Li Y, Yang D. Granulocyte colony-stimulating factor administration for infertile women with thin endometrium in frozen embryo transfer program. Reprod Sci 2014; 21: 381-385. [DOI:10.1177/1933719113497286]
35. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in invitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril 2014; 101: 710-715. [DOI:10.1016/j.fertnstert.2013.12.016]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
